{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:36:09Z","timestamp":1790757369999,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.msard.2024.105738","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T17:29:23Z","timestamp":1718904563000},"page":"105738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosis"],"prefix":"10.1016","volume":"88","author":[{"given":"Riley","family":"Bove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Applebee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Bawden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Belviso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinyee","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieruo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0232-278X","authenticated-orcid":false,"given":"Sarah M","family":"England","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Vignos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105738_bib0001","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jamapsychiatry.2020.3550","article-title":"Trends in suicidality 1 year before and after birth among commercially insured childbearing individuals in the United States, 2006-2017","volume":"78","author":"Admon","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.msard.2024.105738_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1258\/om.2012.110014","article-title":"Pregnancy and multiple sclerosis","volume":"5","author":"Airas","year":"2012","journal-title":"Obstet. Med."},{"key":"10.1016\/j.msard.2024.105738_bib0003","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1212\/WNL.0b013e3181fd62bb","article-title":"Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis","volume":"75","author":"Amato","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/NDT.S292734","article-title":"Perinatal mental health disorders: a review of lessons learned from obstetric care settings","volume":"19","author":"Ayala","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.msard.2024.105738_bib0005","first-page":"12","article-title":"Pregnancy management in multiple sclerosis and other demyelinating diseases","volume":"28","author":"Bove","year":"2022","journal-title":"Continuum"},{"key":"10.1016\/j.msard.2024.105738_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103955","article-title":"Fatigue in multiple sclerosis is associated with socioeconomic factors","volume":"64","author":"Broch","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0007","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/13524585221129963","article-title":"Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis","volume":"29","author":"Calocer","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105738_bib0008","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3949\/ccjm.90a.22066","article-title":"Reproductive issues and multiple sclerosis: 20 questions","volume":"90","author":"Carlson","year":"2023","journal-title":"Clevel. Clin. J. Med."},{"key":"10.1016\/j.msard.2024.105738_bib0009","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/s12325-018-0799-5","article-title":"Outcomes of stable multiple sclerosis patients staying on initial interferon beta therapy versus switching to another interferon beta therapy: a US claims database study","volume":"35","author":"Cohan","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.msard.2024.105738_bib0010","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1212\/WNL.0000000000005574","article-title":"Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS","volume":"90","author":"Corboy","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0011","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1756285616631897","article-title":"Management of women with multiple sclerosis through pregnancy and after childbirth","volume":"9","author":"Coyle","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0012","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.msard.2019.04.003","article-title":"Management strategies for female patients of reproductive potential with multiple sclerosis: an evidence-based review","volume":"32","author":"Coyle","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0013","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1212\/WNL.0000000000201242","article-title":"In vitro fertilization and multiple sclerosis: evolving treatments and reducing relapse risk","volume":"99","author":"Dobson","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0014","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1212\/WNL.0000000000012062","article-title":"Perinatal depression and anxiety in women with multiple sclerosis: a population-based cohort study","volume":"96","author":"Eid","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12883-022-02738-7","article-title":"Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis","volume":"22","author":"Fox","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2024.105738_bib0016","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clineuro.2012.04.024","article-title":"The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis","volume":"115","author":"Fragoso","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105738_bib0017","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?","volume":"3","author":"Gajofatto","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.msard.2024.105738_bib0018","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1089\/jwh.2021.0338","article-title":"Postpartum hospital readmissions and emergency department visits among high-risk, Medicaid-insured women in New York City","volume":"31","author":"Glazer","year":"2022","journal-title":"J. Womens Health"},{"key":"10.1016\/j.msard.2024.105738_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40120-015-0033-1","article-title":"Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience","volume":"4","author":"Gold","year":"2015","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2024.105738_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jnnp-2023-331525","article-title":"Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis","volume":"95","author":"Haben","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105738_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/20420986221143830","article-title":"Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy","volume":"14","author":"Haker","year":"2023","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.msard.2024.105738_bib0022","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756285612453192","article-title":"Multiple sclerosis and pregnancy: experience from a nationwide database in Germany","volume":"5","author":"Hellwig","year":"2012","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0023","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001114","article-title":"Interim analysis of pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry","volume":"9","author":"Hellwig","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105738_bib0024","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/1352458513507816","article-title":"Predictors and dynamics of postpartum relapses in women with multiple sclerosis","volume":"20","author":"Hughes","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105738_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12883-020-01882-2","article-title":"Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States","volume":"20","author":"Kern","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2024.105738_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103860","article-title":"A cross-sectional analysis of persistence to disease-modifying therapies in treatment naive and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacy","volume":"63","author":"Kozlicki","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0027","doi-asserted-by":"crossref","first-page":"e1939","DOI":"10.1212\/WNL.0000000000009374","article-title":"Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort","volume":"94","author":"Langer-Gould","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0028","doi-asserted-by":"crossref","first-page":"e1916","DOI":"10.1212\/WNL.0000000000201027","article-title":"Assessing the risk of relapse requiring corticosteroids after in vitro fertilization in women with multiple sclerosis","volume":"99","author":"Mainguy","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0029","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/13524585231190771","article-title":"Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis","volume":"29","author":"Marrie","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105738_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105738_bib0031","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10900-014-9913-z","article-title":"Complementary and alternative medicine use and nutrient intake among individuals with multiple sclerosis in the United States","volume":"40","author":"Masullo","year":"2015","journal-title":"J. Community Health"},{"key":"10.1016\/j.msard.2024.105738_bib0032","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40264-021-01113-8","article-title":"Validating claims-based algorithms determining pregnancy outcomes and gestational age using a linked claims-electronic medical record database","volume":"44","author":"Moll","year":"2021","journal-title":"Drug Saf."},{"key":"10.1016\/j.msard.2024.105738_bib0033","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.msard.2019.01.003","article-title":"Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study","volume":"28","author":"Nguyen","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0034","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s41669-017-0035-2","article-title":"Comparison of disease-modifying therapies for the management of multiple sclerosis: analysis of healthcare resource utilization and relapse rates from US insurance claims data","volume":"2","author":"Nicholas","year":"2018","journal-title":"Pharmacoecon. Open"},{"key":"10.1016\/j.msard.2024.105738_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103921","article-title":"Dimethyl fumarate is associated with lower rates of infection and lower infection-related healthcare costs when compared with ocrelizumab","volume":"63","author":"Nicholas","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105738_bib0036","first-page":"469","article-title":"Clinical and economic impact of glatiramer acetate versus beta interferon therapy among patients with multiple sclerosis in a managed care population","volume":"8","author":"Ollendorf","year":"2002","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.msard.2024.105738_bib0037","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/10547738231177480","article-title":"Motherhood experiences of women with multiple sclerosis: a thematic meta-synthesis","volume":"32","author":"Ozkan","year":"2023","journal-title":"Clin. Nurs. Res."},{"key":"10.1016\/j.msard.2024.105738_bib0038","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archneur.63.4.611","article-title":"Not every patient with multiple sclerosis should be treated at time of diagnosis","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2024.105738_bib0039","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105738_bib0040","first-page":"1","article-title":"Updated methodology to estimate overall and unintended pregnancy rates in the United States. National Center for Health Statistics","volume":"2","author":"Rossen","year":"2023","journal-title":"Vital Health Stat."},{"key":"10.1016\/j.msard.2024.105738_bib0041","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/13524585231223395","article-title":"Use of multiple sclerosis disease-modifying therapies during pregnancy in France: nationwide study between 2010 and 2021","volume":"30","author":"Swital","year":"2024","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105738_bib0042","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1093\/brain\/awab342","article-title":"Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis","volume":"144","author":"Vasileiou","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.105738_bib0043","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrneurol.2015.53","article-title":"Multiple sclerosis and pregnancy in the 'treatment era'","volume":"11","author":"Vukusic","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2024.105738_bib0044","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105738_bib0045","doi-asserted-by":"crossref","first-page":"e2989","DOI":"10.1212\/WNL.0000000000012084","article-title":"Natalizumab, fingolimod and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis","volume":"96","author":"Yeh","year":"2021","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824003158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824003158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T03:21:59Z","timestamp":1723605719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824003158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":45,"alternative-id":["S2211034824003158"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105738","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105738"}}